Post Profile






Glaxo sells stake in SA’s Aspen

GlaxoSmithKline has disposed of the final portion of its stake in South African drug company Aspen. ||| London - GlaxoSmithKline, the UK’s biggest drugmaker, disposed of the final portion of its stake in Aspen Pharmacare for about $619 million, less than a month after selling the South African company a portfolio of anaesthetic medicines. Glaxo sold 28.2 million shares, equal to 6.
read more

share

Related Posts


GlaxoSmithKline raises R7.1bn from Aspen share sale

Business & Finance : Business Report

GlaxoSmithKline said it had completed the sale of 28.2 million Aspen Pharmacare shares, raising proceeds of 7.059 billion rand. ||| London - GlaxoSmithKline said on Wednesday it had completed the sale of 28.2 million shares in Aspen...

GSK, Aspen in $1bn drugs deal

Business & Finance : Business Report

GlaxoSmithKline is discussing the sale of its thrombosis brands to Aspen Pharmacare in a deal that could be worth $1 billion. ||| London - GlaxoSmithKline is discussing the sale of its thrombosis drug brands Arixtra and Fraxiparine,...

Glaxo joins Alphabet in medical venture

Business & Finance : Business Report

Drug manufacturer GlaxoSmithKline teams up with Google’s parent company to research and develop bioelectronic medicines. ||| London - GlaxoSmithKline, the UK’s biggest drugmaker, is forming a joint venture with Google parent Alphabe...

Aspen’s deal spree continues

Business & Finance : Business Report

Drug manufacturer Aspen Pharmacare has agreed to buy a portfolio of anaesthetic medicines from GlaxoSmithKline. ||| Johannesburg - Aspen Pharmacare agreed to buy a portfolio of anaesthetic medicines from GlaxoSmithKline for as much ...

GSK sells anesthetics to Aspen for up to $370 million

Health : Reuters: Health

LONDON (Reuters) - GlaxoSmithKline is to sell its portfolio of anesthetic drugs to South Africa's Aspen Pharmacare for up to 280 million pounds ($372 million) as part of a drive by the British drugmaker to focus on core therapy area...

Comments


Copyright © 2016 Regator, LLC